Women’s reproductive healthcare gets boost with home blood-testing kit for fertility
Women's fertility issues received a boost, as health start-up Yesmom announced the launch of Asia's first at-home blood testing kits for female fertility, designed...
RedHill Biopharma expands manufacturing capacity of Opaganib for COVID-19 with Cosmo Pharma
RedHill Biopharma Ltd has announced a manufacturing agreement with Cosmo Pharmaceuticals NV.
According to the specialty biopharmaceutical company, the partnership is to further expand manufacturing...
GSK and Medicago commence Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Medicago and GSK have announced the beginning of Phase 2/3 clinical trials of plant-derived vaccine candidate for Covid-19.
The study is being done to assess...
Sputnik V vaccine’s efficacy confirmed at 91.4%
Sputnik V, the Russian Covid-19 vaccine, has passed a crucial test. Its efficacy has been confirmed at 91.4 per cent bsed on data analysis...
Oramed Pharmaceuticals Inc starts Phase 3 Trial of Oral Insulin
Oramed Pharmaceuticals Inc announced that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for...
BAT moves Covid candidate vaccine towards Phase I human clinical trials
BAT has announced plans to commence a Phase I first-time-in-human study of its Covid-19 vaccine candidate.
The announcement by BAT's US Bio-tech arm, Kentucky BioProcessing...
Aster Labs unveils Digital Pathology Solution approved by USFDA
Aster Labs has introduced US FDA approved digital pathology solution at two of its facilities.
The diagnostics arm of Aster DM Healthcare, a healthcare service...
Daewoong, Sygnature Discovery eyes autoimmune disease research
South Korea-based Daewoong Pharmaceutical has entered a research collaboration with Sygnature Discovery to expand its global open innovation for novel drug development.
Daewoong Pharmaceutical enters...
Dr. Reddy’s to buy Glenmark’s select anti-allergy brands in Russia, Kazakhstan, Ukraine, Uzbekistan
Hyderabad-based Dr. Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement with Glenmark Pharmaceuticals Ltd. to acquire the latter's select anti-allergy...
Biocon Biologics gets $150 mn capital dose from Goldman Sachs
The Board of Biocon Biologics Ltd has approved a Rs 1,125 Crore (~USD 150 million) capital injection from Goldman Sachs.
Biocon Biologics is a subsidiary...